HDAC3 Regulates Ferroptosis via Nrf2–GPX4 Signaling in Colorectal Cancer Cells
Open Access
- 1 August 2025
- journal article
- research article
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 523 (1) , 424-433
Abstract
Ferroptosis, an iron-dependent form of regulated cell death, represents an emerging therapeutic vulnerability in colorectal cancer (CRC). However, the epigenetic mechanisms controlling ferroptosis sensitivity in CRC remain poorly understood. Here, we identify histone deacetylase 3 (HDAC3) as a pivotal epigenetic suppressor of ferroptosis. Both pharmacological inhibition and genetic knockdown of HDAC3 significantly enhanced ferroptosis sensitivity, as evidenced by elevated intracellular ferrous iron (Fe 2+ ) and lipid peroxidation. Mechanistically, inhibition of HDAC3 reduced the expression of nuclear factor erythroid 2–related factor 2 (NRF2), a master antioxidant transcription factor, thereby leading to downregulation of glutathione peroxidase 4 (GPX4), a central ferroptosis defense gene. Notably, NRF2 knockdown abolished GPX4 downregulation by HDAC3 inhibition, whereas GPX4 overexpression rescued the ferroptotic phenotype caused by HDAC3 depletion. Collectively, these findings define an HDAC3–NRF2–GPX4 axis that suppresses ferroptosis in CRC, and highlight HDAC3 as a potential therapeutic target for ferroptosis-based cancer treatment.Keywords
This publication has 13 references indexed in Scilit:
- HAT1/HDAC2 mediated ACSL4 acetylation confers radiosensitivity by inducing ferroptosis in nasopharyngeal carcinomaCell Death & Disease, 2025
- Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal CancerAdvanced Science, 2025
- The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseasesMedcomm, 2023
- NOD2‐mediated HDAC6/NF‐κb signalling pathway regulates ferroptosis induced by extracellular histone H3 in acute liver failureJournal of Cellular and Molecular Medicine, 2022
- Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapySignal Transduction and Targeted Therapy, 2022
- Ferroptosis in cancer therapy: a novel approach to reversing drug resistanceMolecular Cancer, 2022
- Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor CellsAdvanced Science, 2021
- Inhibiting HDAC3 (Histone Deacetylase 3) Aberration and the Resultant Nrf2 (Nuclear Factor Erythroid-Derived 2-Related Factor-2) Repression Mitigates Pulmonary FibrosisHypertension, 2021
- USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3Oncogenesis, 2020
- GPX4 at the Crossroads of Lipid Homeostasis and FerroptosisProteomics, 2019